Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
Health insurance premiums rose nearly 3x the rate of worker earnings over the past 25 years- Netanyahu leads meeting on West Bank riots, Katz defends axing administrative detention for Jews
- 5 Must-Attempt Fascinating Dishes from Around the World
- Step by step instructions to Think about Disc Rates Across Various Banks
- Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds
- 'All Her Fault' ending explained: The shocking conclusion to the psychological thriller inspired by true events
- Mysterious bright blue cosmic blasts triggered by black holes shredding stars, scientists say. 'It's definitely not just an exploding star.'
- Manual for Conservative SUVs For Seniors
- Find the Standards of Powerful Cooperation: Accomplishing Cooperative energy and Coordinated effort
